Ligand Pharmaceuticals Incorporated - Common Stock — Quarterly Cash Flow (NASDAQ:LGND) | MetaTrader

Open full chart

Financials

Overview Statement Statistics Dividends

Quarterly Annual

Total assets 905.43 M948.6 M1.48 B1.56 B1.53 B Total liabilities 109.9 M120.08 M526.6 M543.42 M534.78 M Total equity 795.53 M828.53 M950.17 M1.02 B997.32 M Total liabilities & shareholders' equities 905.43 M948.6 M1.48 B1.56 B1.53 B Total debt ——445.49 M446.22 M446.9 M Net debt ——-219.03 M-287.31 M-332.51 M

News

Why Is Agenus Stock Gaining Monday? - Agenus (NASDAQ:AGEN)

Macro Note: The Tech Unwind Grew A Second Leg, And It’s Healthcare

Ligand (LGND): Expect Bright And Exciting Future For This Growing Royalty Aggregator

Ligand Pharma (LGND): Bull Case Is A Biotech ARM, Bear Case Is Just Another Royalty Trust

Stocks Mostly Lower on Weakness in Megacap Tech and Software Stocks

Stocks Erase Early Gains as Alphabet and Software Companies Fall

Stocks Supported by Strength in Chipmakers and AI-Infrastructure Stocks

Stock Market Today: Nasdaq, Dow Sink As Chip Stocks Slide, Trump Warns. A Biotech Breaks Out. (Live Coverage)

Ligand Pharmaceuticals Incorporated (LGND) Q1 2026 Earnings Call Transcript

Ligand Pharmaceuticals Incorporated 2026 Q1 - Results - Earnings Call Presentation (NASDAQ:LGND) 2026-05-08

Ligand Pharmaceuticals Incorporated (LGND) XOMA Royalty Corporation - M&A Call - Slideshow (NASDAQ:LGND) 2026-04-27

Royalty Powerhouse: Ligand And Xoma Unite In $739 Million Deal